AHMED HUSSEIN: Open Payments
NPI 1851910749 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 22 payments from 7 companies in 2025. Trend: 2023 $884 · 2024 $361 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $213 |
| Teva Pharmaceuticals USA, Inc. | 5 | $164 |
| Alkermes, Inc. | 3 | $62 |
| Braeburn Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: CAPLYTA, UZEDY, ARISTADA, BRIXADI, VRAYLAR, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across MI — which companies pay providers there.
